Merck's late-stage KEYNOTE-355 trial met endpoint of overall survival in breast cancer study
July 27 2021 - 7:53AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024